PA Health Law Project Newsletter
The Pennsylvania Health Law Project has published its September 2020 newsletter Health Law News.
Included in this month’s edition are articles about:
- How Pennsylvania Medicaid beneficiaries who turn 21 during the COVID-19 emergency remain eligible for EPSDT services.
- Pennsylvania Health Law Project navigators who can help direct people to COVID-19 testing and treatment.
- A warning that without increased federal Medicaid matching money, states may seek to reduce Medicaid provider payments, increase beneficiary cost-sharing, or reduce services.
Read about these subjects and more in the Pennsylvania Health Law Project’s September 2020 newsletter.
Secretary Levine has ordered ambulatory surgical facilities to report on specific items for the purpose of managing supplies and equipment. Portions of the survey are to be updated each day, including the number of procedures they perform and their remaining supplies of personal protective equipment.
The Department of Human Services (DHS)’ Office of Mental Health and Substance Abuse Services has sent an FAQ to HealthChoices behavioral health managed care organizations, fee-for-service providers, and county mental health authorities on the subject of behavioral health Medicaid programs and the COVID-19 crisis. Find that FAQ
The Families First Coronavirus Response Act, signed into law on March 18, includes a temporary 6.2 percentage point increase in the federal medical assistance percentage (FMAP: the rate at which the federal government matches state Medicaid expenditures). A new CMS FAQ provides information about the state Medicaid expenditures to which the increase applies, its applicability to Medicaid DSH payments, the duration of the supplemental funding, and more. Find this FAQ
The Department of Drug and Alcohol Programs (DDAP) has issued a document clarifying the state’s response to federal guidance on the disclosure of patients’ substance abuse disorder records during the telehealth process. See that policy clarification
The legislature continues to deliberate on a number of measures to respond to the COVID-19 crisis. Among the issues being discussed between the administration and legislature are:
Since yesterday, the Department of Human Services has issued the following four new guidance documents:
Federal
PACE Prescription Drug Program